Metformin combined with gefitinib produced a synergistic effect in LKB1 wild-type NSCLC cells [39], and metformin has the ability to inhibit the metastasis of Lewis lung cancer [40] through the adenosine monophosphate-activated protein kinase α1 pathway. This evidence concerns the gene STK11 and non-small cell lung carcinoma.